as on January 12, 2026 at 4:01 pm IST
Day's Low
Day's High
3.69%
Downside
9.48%
Upside
52 Week's Low
52 Week's High
3.69%
Downside
81.14%
Upside
as on January 12, 2026 at 4:01 pm IST
Market Cap
₹144.26 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
1.29
P/B Ratio
-0.98
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
6.6
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Krebs Biochemicals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 144.26 | -9.85% | 0.00 | -27 | 43 | |
| NA | 196.69 | 12% | 0.00 | 4 | 473 | |
| NA | 391.06 | 24.02% | 0.68 | 18 | 344 | |
| NA | 9.08 | -16.42% | 0.84 | -1 | 7 | |
| NA | 152.58 | -7.89% | 0.00 | 9 | 118 |
Get share price movements and forecasts by analysts on Krebs Biochemicals.
Source: S&P Global Market Intelligence
Search interest for Krebs Biochemicals & Industries Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Krebs Biochemicals.
Krebs Biochemicals & Industries Ltd’s net profit fell -6.6% since last year same period to ₹-6.14Cr in the Q2 2025-2026. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -15.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 72.74% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 156.3% return, outperforming this stock by 191.9%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 22.5% return, outperforming this stock by 45.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 26.76% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 3 years, KREBSBIO stock has moved down by -35.6%
| Organisation | Krebs Biochemicals & Industries Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | R T Ravi |
| E-voting on shares | Click here to vote |
Krebs Biochemicals share price today stands at ₹62.66 as on at the close of the market. Krebs Biochemicals share today touched a day high of ₹68.6 and a low of ₹60.35.
Krebs Biochemicals touched a 52 week high of ₹113.5 and a 52 week low of ₹60.35. Krebs Biochemicals share price today i.e. is closed at ₹62.66, which is -44.79% down from its 52 week high and 3.83% up from its 52 week low.
Krebs Biochemicals market capitalisation is ₹144.26 Cr as on .
To buy Krebs Biochemicals shares, you need to follow these steps:
Krebs Biochemicals trading volume is 8,384.00 as on . This means that 8,384.00 shares of Krebs Biochemicals were bought and sold on the stock market during today's trading session.